Clinical Trial Update: The Optimal Strategy of Switching From Clopidogrel to Ticagrelor in Patients With Complexity of Coronary Artery Disease [NA]

View source ↗

Summary

This completed trial update discusses the optimal strategy for switching from clopidogrel to ticagrelor in patients with complex coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Coronary Artery Disease, Ticagrelor | NA | Status: COMPLETED